Equity Research firms currently have a positive stance on shares of Lipocine Inc. (NASDAQ:LPCN). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.50. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $17.00 on a short term basis.
At the time of writing, the stock was trading at $5.29. This represents a change from the opening price of 1.75%. In terms of performance, year to date, the stock is -67.75%. The monthly stock performance comes in at 25.23%. For the quarter, shares are performing at 24.85%. Weekly performance analysis shows the equity at 2.71%.
In taking a look at technical levels, shares are trading 39.63% away from the 50 day simple moving average and -31.09% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -64.24% away from it’s 52- week high and 110.80% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Lipocine Inc.’s RSI stands at 69.82. In looking at volatility levels, the shares saw weekly volatility of 8.44% and 8.34% over the past month.